Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.93 USD | +4.89% | +4.32% | +36.88% |
Sales 2024 * | 250K 342K | Sales 2025 * | 250K 342K | Capitalization | 323M 442M |
---|---|---|---|---|---|
Net income 2024 * | -133M -182M | Net income 2025 * | -151M -206M | EV / Sales 2024 * | 1,065 x |
Net cash position 2024 * | 56.8M 77.64M | Net cash position 2025 * | 168M 230M | EV / Sales 2025 * | 619 x |
P/E ratio 2024 * |
-2.49
x | P/E ratio 2025 * |
-2.51
x | Employees | 83 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.01% |
Latest transcript on Atai Life Sciences N.V.
1 day | +4.89% | ||
1 week | +4.32% | ||
Current month | -2.03% | ||
1 month | +7.82% | ||
3 months | +12.21% | ||
6 months | +82.08% | ||
Current year | +36.88% |
Managers | Title | Age | Since |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 18-05-31 |
Srinivas Rao
FOU | Founder | 55 | 18-05-31 |
Anne Johnson
DFI | Director of Finance/CFO | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 20-12-31 |
Founder | 46 | 18-05-31 | |
Amir Kalali
BRD | Director/Board Member | 58 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.93 | +4.89% | 875,491 |
24-04-25 | 1.84 | -1.60% | 822,238 |
24-04-24 | 1.87 | -5.08% | 842,720 |
24-04-23 | 1.97 | +5.35% | 1,200,332 |
24-04-22 | 1.87 | +1.08% | 1,049,274 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.88% | 323M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ATAI Stock